Newark, New Castle, USA, June 15, 2023 (GLOBE NEWSWIRE) -- The market analysis of the global immunostimulants market was conducted by Growth Plus Reports in 2022 and is valued at US$ 107.61 billion.

The immunostimulants market in Germany is expected to grow at a 6.4% CAGR over the next ten years. The oncology segment will account for 34.7% of the total market share by 2032, which is a ...

The global immunostimulants market is set to witness sustained and robust expansion between 2025 and 2035, driven by a confluence of medical, technological, and societal trends. With a projected CAGR ...

Global immunostimulants industry in 2022 was US$ 108.22 billion and is estimated to be US$ 113.54 billion in 2023. Future Market Insights has mentioned in its reports that the immunostimulants ...

The principal types of toxicity studies required for adjuvanted vaccines and adjuvants/ immunostimulants during vaccine clinical development are summarized below: Exploratory phase (non-GLP) Single ...

In addition to improving our understanding of target antigens for vaccines and their correlates of protection, recent advances in immunological research, particularly in our understanding of ...